欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/4801/001
药品名称	Prednison mibe 100 mg Zäpfchen
活性成分	prednisone 0.1 g
剂型	Suppository
上市许可持有人	Mibe GmbH Arzneimittel Münchener Str. 15 D-06796 Brehna Germany
参考成员国 - 产品名称	Germany (DE) Prednison mibe 100 mg Zäpfchen
互认成员国 - 产品名称	Netherlands (NL) Spain (ES) Italy (IT)
许可日期	2019/01/03
最近更新日期	2023/08/02
药物ATC编码	H02AB07 prednisone
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	PAR \| DE_4800_4801_1_DC_PARDate of last change:2022/11/28 Final PL \| de_pal_4800_202202_cvDate of last change:2022/06/07 Final PL \| common_pal_4800_4801_202202_cvDate of last change:2022/06/07 Final PL \| common_pal_4800_4801_202202_hvDate of last change:2022/06/07 Final PL \| de_pal_4800_202202_hvDate of last change:2022/06/07 Final SPC \| de_spc_4800_202202_cvDate of last change:2022/06/07 Final SPC \| common_spc_4800_4801_202202_cvDate of last change:2022/06/07 Final SPC \| de_spc_4800_202202_hvDate of last change:2022/06/07 Final SPC \| common_spc_4800_4801_202202_hvDate of last change:2022/06/07 Final Product Information \| labip-prednisone-201811-cvDate of last change:2019/02/22 Final Product Information \| spcen-prednison-201901-cvDate of last change:2019/02/22 Final Product Information \| labop-prednisone-201812-cvDate of last change:2019/02/22 Final Product Information \| palen-prednisone-201901-cvDate of last change:2019/02/22
市场状态	Positive